Metabolic Disease Oncology Inflammation CNS Cardiovascular Partners
 
 
     
  Plexxikon in the News  
     
  Below are news articles about Plexxikon.

3/08


10/9/06


10/5/06



10/3/06



11/5/04


6/14/04


4/16/04



7/14/03


6/15/03



5/21/03



7/02 - 8/02



4/29/02


3/14/02		 R&D Directions - 100 Greatest Investigational Drugs
Read the article

BioCentury - Plexing its platform
Read the article

BioWorld Today - Plexxikon enters Roche deal on B-Raf inhibitors for $706M
Read the article

BioWorld Today - Plexxikon, Servier in potential $100M CV drug discovery deal
Read the article

East Bay Business Times - Plexxikon ventures into tough market
Read the article

BioCentury - Trying to beat PPAR
Read the article

Bio-IT World - Finding the perfect fit - fragment-based drug discovery is producing hits
Read the article

BioCentury - The post industrial age
Read the article

Genetic Engineering News - Structural Proteomics extends its contributions
Read the article

BioWorld Today - Plexxikon enters first partnership, signs deal with rising Genentech
Read the article

Start Up - Windhover's review of emerging medical ventures - turning the hit-to-lead concept on its head
Read the article

BioCentury - Plexxikon: emerging company profile
Read the article

BioWorld Today - Plexxikon's scaffold discovery factory mines protein families
Read the article

Back to Top
 
     
 
Metabolic Disease | Oncology | Inflammation | CNS | Cardiovascular | Partners
Home | About Plexxikon | Investors | News | Clinical Trials | Careers | Contact Us | Site Map
© 2007 Plexxikon Inc. | Site design by Heiney & Craig